| Company Name |
Short Summary |
| Abwiz Bio |
Abwiz Bio is focused on providing researchers with monoclonal antibodies
through immunization and cloning methods using phage display technology. |
| Acadia Pharmaceuticals |
Acadia Pharmaceuticals is an integrated drug discovery company focused on the identification of novel lead compounds for the treatment of Central Nervous Systems disorders. |
| Accelovance |
Accelovance is focused on providing full-Service CRO services, clinical sites, and patient recruitment for biotechnology, pharmaceutical, and medical device companies. |
| Accumetrics |
Accumetrics is a biotech company focused on the design, development, manufacturing, and marketing of innovative point-of-care cardiovascular diagnostic products. |
| ACON Laboratories |
ACON Laboratories is focused on the development and commercialization of rapid diagnostic tests. |
| Adjuvant Partners |
Adjuvant Partners is focused on providing business development and strategic consulting to advanced therapies and regenerative medicine companies. |
| Alere |
Alere is focused on combining diagnostics with health management services to help determine the best course of treatment. |
| Allylix |
Allylix has developed proprietary technology that allows it to produce terpenes at low cost. |
| Althea Technologies |
Althea Technologies is a fully-integrated contract development and manufacturing organization. |
| Ambit Biosciences |
Ambit Biosciences is focused on the discovery and development of small-molecule kinase inhibitors for the treatment of cancer. |
| Amicus Therapeutics |
Amicus Therapeutics is focused on development or oral drugs called pharmacological chaperones for treating a broad range of diseases focused initially on lysosomal storage disorders and diseases of neurodegeneration. |
| AnaptysBio |
AnaptysBio, Inc is a therapeutic antibody company focused on the use of somatic hypermutation (SHM) for antibody discovery and optimization. |
| Apricus Biosciences |
Apricus Biosciences is focused on the development and commercialization of drugs across numerous therapeutic classes. |
| AquaBounty Technologies |
AquaBounty Technologies is focused on the application of biotechnology to improving productivity in commercial aquaculture. |
| Ardea Biosciences |
Ardea Biosciences is focused on the research and development of small-molecule therapeutics with an initial focus on gout, cancer, and HIV. |
| Arena Pharmaceuticals |
Arean Pharmaceuticals is involved in developing a broad pipeline of compounds that act on G protein-coupled receptors, or GPCRs. |
| aTyr Pharma |
aTyr Pharma is focused on the research and development of human proteins that function in extracellular signaling. |
| AVIVA Biosciences |
AVIVA Biosciences is focused on the research, development, and commercialization of cell-based assays. |
| Axxin |
Axxin is focused on the development and commercialization of point of care diagnostics. |
| Becton Dickinson |
Becton Dickinson manufactures and sells medical supplies and devices and diagnostic systems for use by healthcare professionals, research institutions, industry and the general public. |
| BioAtla |
BioAtla is a biological service company specializing in next generation protein and antibody engineering and evolution services. |
| Biocept |
Biocept is focused on using cell separation technology to develop diagnostic assays for personalized medicine in early detection, diagnosis and monitoring of cancer. |
| BioSurplus |
BioSurplus is focused on providing equipment management solutions and pre-owned scientific instruments to the life sciences industry. |
| Cadence Pharmaceuticals |
Cadence Pharmaceuticals focused on in-licensing, developing and commercializing proprietary product candidates principally perscribed and used in the hospital setting. |
| Cato Research |
Cato Research is a global is a full-service contract research and development organization (CRO). |
| Celgene |
Celgene is a pharmaceutical company with a major focus on the discovery, development and commercialization of small molecules for cancer and immunological diseases. |
| Celladon |
Celladon is focused on developing molecular therapies for cardiovascular diseases. |
| Cellana |
Cellana is focused on the development and commercialization of algae-based bioproducts. |
| Ceregene |
Ceregene is focused on the treatment of major neurodegenerative diseases by unique delivery of nervous system growth factors. |
| Charles River Laboratories |
Charles River Laboratories is a global provider of solutions that advance the drug discovery and development process. Charles River Laboratories is the largest laboratory animal production company in the world, and also offers a number of preclinical and clinical support capabilities. |
| ChemDiv |
ChemDiv is a contract discovery and development organization. ChemDiv is a provider of integrated discovery and development solutions focused on a chemistry platform. |
| CoDa Therapeutics |
CoDa Therapeutics is focused on the research and development of wound care therapeutics. |
| Conatus Pharmaceuticals |
Conatus Pharmaceuticals is focused on the development of drugs to treat liver disease |
| Covance |
Covance is one of the world's largest and most comprehensive drug development services companies. |
| Crinetics Pharmaceuticals |
Crinetics Pharmaceuticals is focused on the discovery, research, and development of small molecule drugs for the treatment of endocrine-related diseases and cancers. |
| Cytori Therapeutics |
Cytori Therapeutics is focused on the development and commercialization of the Celution® System, which isolates stem and regenerative cells from adipose tissue. |
| eBioscience |
eBioscience is focused on the research, development, and commercialization of antibodies, ELISAs and proteins for life science research and diagnostic applications. |
| Elcelyx Therapeutics |
Elcelyx Therapeutics is focused on the research and development of products based on novel Gut Sensory Modulation (GSM) technology. |
| Eli Lilly |
Eli Lilly and Company is involved in the discovery, development, manufacture, and marketing of prescription medicines worldwide. |
| Fate Therapeutics |
Fate Therapeutics is focused on the research and development of therapeutics derived from stem cell biology. |
| Gen-Probe |
Gen-Probe is the recognized world leader in the development, manufacture and commercialization of diagnostic products based on its patented genetic probe technology. |
| Genelux Corporation |
Genelux Corporation is focused on the research and development of an oncolytic virus based technology for the treatment of cancer. |
| Genomatica |
Genomatica is focused on the development and application of it's Integrated Bioprocess Engineering Platform. This platform is an integrated suite of computational and experimental technologies used to design, create, and optimize novel high-performance microorganisms for chemical production. |
| GlycoRegImmune |
GlycoRegImmune is focused on the research and development of Natural Killer T cell (NKT) targeted therapies for inflammatory diseases. |
| Halozyme Therapeutics |
Halozyme Therapeutics is a focused on products targeting the extracellular matrix for endocrinology, oncology, dermatology and drug delivery. |
| Harbor Therapeutics |
Harbor Therapeutics is focused on the research and development of novel adrenal steroid hormones and nutraceuticals. |
| HemaQuest Pharmaceuticals |
HemaQuest Pharmaceuticals is focused on the development of small molecule drugs for treatment of hematologic disorders. |
| Histogen |
Histogen is focused on the research, development, and commerialization of products derived from the company's tissue-engineering platform. |
| Hologic |
Hologic is focused on the development and commercialization of diagnostic products, medical imaging systems, and surgical products for women's healthcare. |
| Hospira |
Hospira is focused on commercialization of generic acute-care and oncology injectables and integrated infusion therapy and medication management solutions. Hospira also provides contract manufacturing services to pharmaceutical and biotechnology companies for injectable products. |
| HUYA Bioscience International |
HUYA Bioscience International is a is focused on global co-development of novel biopharmaceutical product opportunities originating in China. |
| Ichor Medical Systems |
Ichor Medical Systems is focused on development of electroporation technology for the delivery of DNA drugs and vaccines. |
| Ignyta |
Ignyta is focused on the disocovery and development of small molecule drugs for the treatment of patients with cancer. |
| Illumina |
Illumina is focused on the research, development, and manufacture of integrated systems for the analysis of genetic variation and biological function. |
| INC Research |
INC Research is a contract research organization (CRO) focused on managing clinical trials in cancer, infectious diseases, and central nervous system disorders. |
| Innovus Pharma |
Innovus Pharma is focused on the commercialization of over-the-counter medicines and consumer and health products. |
| Inovio Biomedical Corporation |
Inovio Biomedical Corporation is focused on electroporation-based delivery of DNA vaccines. |
| Integrated DNA Technologies |
Integrated DNA Technologies has been advancing biotechnology research as both a leading supplier of custom oligonucleotide synthesis and a developer of innovative new biotechnologies. |
| Intercept Pharmaceuticals |
Intercept Pharmaceuticals is focused on the development and commercialization of treatments for patients with chronic liver diseases. |
| iTherX |
iTherX is a focused on the discovery and development of treatments for Hepatitis C. |
| Kalos Therapeutics |
Kalos Therapeutics is focused on the research and development of atrial natriuretic peptides (ANPs) to treat patients with cancer. |
| Lpath |
Lpath is focused on the research and development of monoclonal antibodies that target bioactive lipids. |
| MabVax Therapeutics |
MabVax Therapeutics is focused on developing and commercializing vaccines and human antibodies for the treatment of cancer. |
| MEI Pharma |
MEI Pharma is focused on the development of therapies to treat patients with cancer. |
| Memgen |
Memgen is focused on the development of members of the TNF family as cancer therapeutics. |
| MicroConstants |
MicroConstants is a GLP-compliant Contract Research Organization (CRO) providing bioanalytical, pharmacokinetics, drug metabolism, formulation analysis and immunoassay support services to pharmaceutical and biotech companies developing new chemical entities (NCEs). |
| MultiGEN Diagnostics |
MultiGEN Diagnostics is is focused on the commercialization of DNA sequencing for routine clinical diagnosis in infectious disease. |
| Neurocrine Biosciences |
Neurocrine Biosciences is a leading neuroscience company focused on the discovery and development of novel therapeutics for neuropsychiatric, neuroinflammatory and neurodegenerative diseases and disorders. |
| Novartis |
Novartis engages in the research, development, and commercialization of a range of healthcare products. |
| NuVasive |
NuVasive is focused on the development and commercialization of products for the surgical treatment of spine disorders. |
| OncoSec Medical |
OncoSec Medical is focused on the research and development of treatments for patients with advanced-stage skin cancer. |
| Organovo |
Organovo is focused on the research and development of technology to provide three-dimensional tissue building capabilities for research and surgical applications. |
| Orphagen Pharmaceuticals |
Orphagen Pharmaceuticals is focused on the discovery, research and development of small molecule drugs which target orphan nuclear receptors for the treatment of patients with various diseases. |
| Pacira Pharmaceuticals |
Pacira Pharmaceuticals is focused on the research, development, and commercialization of products based on its proprietary DepoFoam® drug delivery technology with a focus in the post-surgical pain market. |
| PAREXEL International |
PAREXEL International is focuse on providing clinical development, regulatory affairs consulting, and commercialization services to biotechnology, pharmaceutical, and medical device companies. |
| PaxVax |
PaxVax if focused on the research and development of vaccines for cholera, avian influenza (H5N1), anthrax, and HIV. |
| Pfenex |
Pfenex is focused on providing protein expression services for a broad range of applications including therapeutic proteins, vaccines, research reagents, and biosimilars. |
| Pharmatek Laboratories |
Pharmatek Laboratories is focused on providing pharmaceutical chemistry development and manufacturing services supporting pharmaceutical & biotechnology companies. |
| Polynoma |
Polynoma is focused on the development and commercialization of a therapeutic vaccine for the treatment of patients with melanoma. |
| PolyPeptide Laboratories |
PolyPeptide Laboratories is a contract manufacturing organization (CMO) focused on providing peptide synthesis services to biotechnology and pharmaceutical companies. |
| PPD |
PPD is focused on drug discovery, development and lifecycle management services to companies in the pharmaceutical, biotechnology, medical device industries. |
| PRA International |
PRA International is a Clinical Research Organization (CRO) focused on providing services for clinical development. |
| Prometheus Laboratories |
Prometheus Laboratories is involved in the disovery, development, manufacture, and marketing of therapeutics and diagnostics in the areas of gastrointestinal, autoimmune and inflammatory diseases. |
| Promosome |
Promosome is focused on the development and commercialization of a technology which enhances protein synthesis for biotherapeutics. |
| Quidel |
Quidel is focused on the research, development, and commercialization of point-of-care, rapid diagnostic tests. |
| Quintiles |
Quintiles is a contract research organization focused on providing integrated bio and pharmaceutical services. Quintiles also offers commercial, consulting and capital services. |
| Receptos |
Receptos is focused on the research and development of candidates for the treatment of patients with autoimmune diseases using bioinformatics and structure driven drug discovery. |
| Regulus Therapeutics |
Regulus Therapeutics is focused on the discovery of a therapeutics based on microRNAs. |
| ResMed |
ResMed is focused on the development and commercialization of medical devices for the diagnosis, treatment, and management of sleep-disordered breathing. |
| RetroVirox |
RetroVirox is focused on the research and development of small molecule antivirals. |
| REVA Medical |
REVA Medical is focused on the development and commercialization of stent technologies. |
| Senomyx |
Senomyx is focused on the discovery and development of flavor ingredients. |
| Sequel Pharmaceuticals |
Sequel Pharmaceuticals is focused development of cardiovascular drug candidates. |
| Sequenom |
Sequenom is focused on the development of discovery, clinical research, and molecular diagnostics asstas which precisely measures the amount of genetic target material and variations therein. |
| SRI |
SRI International is an independent, nonprofit research institute conducting client-sponsored research and development for government agencies, commercial businesses, foundations, and other organizations. SRI also brings its innovations to the marketplace by licensing its intellectual property and creating new ventures. |
| Synbiotics |
Synbiotics is focused on the development and commercialization of veterinary diagnostics and services. |
| Tamir Biotechnology |
Tamir Biotechnology is focused of the development of ribonucleases primarily for the treatment of cancer. |
| Tioga Pharmaceuticals |
Tioga Pharmaceuticals is focused on the research, development, and commercialization of therapies for the treatment of patients with gastrointestinal diseases. |
| Tracon Pharmaceuticals |
Tracon Pharmaceuticals is focused on the development of antibody and small molecule therapies for people with cancer and related diseases. |
| Trovagene |
Trovagene is focused on providing molecular diagnostic services through a CLIA-certified, CAP-accredited laboratory. |
| Verenium |
Verenium is focused on the research, development, and commercialization of enzymes for use in industrial processes. |
| Vertex Pharmaceuticals |
The Company has 12 drug candidates in development to treat viral diseases, inflammation, cancer, autoimmune diseases and neurological disorders. |
| Vical |
Vical is involved in the discovery, research, and development of products based on their DNA delivery technologies (non-viral gene therapy) for the prevention and treatment of serious or life-threatening diseases. |
| Volcano Corporation |
Volcano Corporation is focused on the development and commercialization of medical devices for the diagnosis and treatment of vascular and structural heart disease. |
| Zogenix |
Zogenix is focused on the development and commercialization of products for the treatment of pain and central nervous system disorders. |
| |
